Avista Healthcare

Thompson Dean to Transition to Chairman; David Burgstahler to Become Sole Managing Partner Josh Tamaroff and Alex Yu named Partners as Avista continues to realize significant growth NEW YORK, Aug. 18, 2021 /PRNewswire/ — Avista Capital Partners (“Avista”), a leading private equity firm focused exclusively on healthcare, today announced that effective December 31, 2021,Tom Dean will transition from Co-Managing […]

NEW YORK, Aug. 12, 2021 /PRNewswire/ — Avista Public Acquisition Corp. II (the “Company”), a special purpose acquisition company formed for the purpose of entering into a combination with one or more businesses, announced today the pricing of its initial public offering of 23,000,000 units, which includes 3,000,000 units issued upon the exercise of the underwriters’ overallotment option, […]

NEW YORK, Aug. 9, 2021 /PRNewswire/ — Avista Public Acquisition Corp. II (the “Company”), a special purpose acquisition company formed for the purpose of entering into a combination with one or more businesses, announced today the pricing of its initial public offering of 20,000,000 units at a price of $10.00 per unit.  The units will be listed on the […]

NEW YORK, Aug. 9, 2021 /PRNewswire/ — Avista Capital Partners (“Avista”), a leading private equity firm focused exclusively on healthcare, announced that it has entered into a definitive agreement to sell Arcadia Consumer Healthcare, Inc. (“Arcadia”), a recognized leader in the consumer healthcare market for over-the-counter (“OTC”) medicines and premium vitamins and nutritional supplements, to Bansk Group, […]

Osmotica will receive a $110 million upfront cash payment, with the potential to receive up to $60 million in additional milestone payments Alora will acquire manufacturing operations in Marietta, Georgia in addition to legacy products Osmotica will retain the RVL Pharmaceuticals business focused on ophthalmology and aesthetics, led by its flagship product, UPNEEQ® Osmotica will […]

Plymouth Meeting, Pa. – June 15, 2021 – Braeburn announces that today the New Drug Application (NDA) for BRIXADI (buprenorphine) extended-release injection for subcutaneous (SC) use (CIII) for moderate to severe opioid use disorder was resubmitted to the U.S. Food and Drug Administration (FDA). The resubmission is in response to a Complete Response Letter issued by […]

Vision Healthcare reached an agreement with the shareholders of Sensilab SA for the acquisition of 100% of the shares in Sensilab d.o.o. (“Sensilab” or the “Company”), a high growth EU-wide direct-to-consumer consumer health house of brands. Sensilab was established in 2005 and is headquartered in Ljubljana, Slovenia. The Company has a strong position in the […]

Recently for its Laboratory Innovator series, Medical Laboratory Observer magazine sat down with XIFIN CEO Lâle White to get her take on topics ranging from strategies for coping with upcoming reimbursement cuts to the evolution of federal payment policies to the importance of harnessing information technology to solve the integration and communication problems that undermine […]

Zurich, Switzerland and Moscow, Russia, 1 April 2021 – Acino announced today the completion of the acquisition of select portfolio of brands from the IlmixGroup group of companies in Russia. The transaction includes eight prescription pharmaceutical assets and food supplements in the areas of gynaecology, gynaecologic oncology, urology and dermatology. The parties also entered into manufacturing […]

NEW YORK, March 25, 2021 /PRNewswire/ — Avista Capital Partners (“Avista”), a leading private equity firm focused exclusively on healthcare, today announced that it has signed a definitive agreement to invest in eMolecules (“eMolecules,” or the “Company”), a novel and fast-growing e-procurement platform for high-value chemicals and bioreagents used by the leading pharmaceutical companies in drug discovery. Financial terms […]

London, 12th March 2021: Charterhouse Capital Partners LLP (“Charterhouse”), one of the longest established private equity firms operating in Europe, announces today that it has entered into exclusive negotiations for the sale of a majority stake in Cooper Consumer Health (“Cooper” or “the Company”), a leading European independent over-the-counter (“OTC”) drug manufacturer and distributor, to […]

NEW YORK, March 2, 2021 /PRNewswire/ — Avista Capital Partners (“Avista” or “the Firm”), a leading New York-based healthcare private equity firm, today announced the final closing of Avista Capital Partners V, L.P. and Avista Capital Partners (Offshore) V, L.P. (collectively, “Fund V” or the “Fund”).  Fund V was over-subscribed, hit its hard-cap and substantially exceeded its target of $775 […]